International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 862-867 , 15 July 2002

Stage II endometrial carcinoma: prognostic factors and risk classification in 170 patients

  • Graham Pitson, M.B.B.S.

      Affiliations

    • Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Terence Colgan, M.D. (F.R.C.P.C., F.C.A.P., M.I.A.C.)

      Affiliations

    • Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Wilfred Levin (M.B., F.R.C.P.C.)

      Affiliations

    • Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Gina Lockwood (M.Math.)

      Affiliations

    • Department of Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Lee Manchul, M.D. (F.R.C.P.C.)

      Affiliations

    • Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Michael Milosevic, M.D. (F.R.C.P.C.)

      Affiliations

    • Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Joan Murphy, M.D. (F.R.C.S.C.)

      Affiliations

    • Department of Gynecologic Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Anthony Fyles, M.D. (F.R.C.P.C.)

      Affiliations

    • Corresponding Author InformationReprint requests to: Dr. Anthony Fyles, Department of Radiation Oncology, Princess Margaret Hospital, 610 University Avenue, Toronto, Ontario, M5G 2M9 Canada. Tel: (416) 946-2123; Fax: (416) 946-4586
    • Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada

Received 15 November 2001 ,Revised 20 February 2002 ,Accepted 27 February 2002.

References 

  1. Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer (Treatment trends versus survival for FIGO stage II, 1988–1994). Gynecol Oncol. 1999;74:350–355
  2. Irwin C, Levin W, Fyles A, et al.  The role of adjuvant radiotherapy in carcinoma of the endometrium—results in 550 patients with pathologic stage I disease. Gynecol Oncol. 1998;70:247–254
  3. Scully RE. World Health Organization. In: Histological typing of female genital tract tumors. 2nd ed.. New York: Springer-Verlag; 1994;
  4. Gooley TA, Leisenring W, Crowley J, et al.  Estimation of failure probabilities in the presence of competing risks (New representations of old estimators). Stat Med. 1999;18:695–706
  5. Bozdogan H. Model selection and Akaike’s information criterion (AIC) (The general theory and its analytical extensions). Psychometrika. 1987;52:345–370
  6. Berman ML, Afridi MA, Kanbour AI, et al.  Risk factors and prognosis in stage II endometrial cancer. Gynecol Oncol. 1982;14:49–61
  7. Boente MP, Yordan EL, McIntosh DG, et al.  Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol. 1993;51:316–322
  8. Eltabbakh GH, Moore AD. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol. 1999;74:80–85
  9. Calvin DP, Connell PP, Rotmensch J, et al.  Surgery and postoperative radiation therapy in stage II endometrial carcinoma. Am J Clin Oncol. 1999;22:338–343
  10. Feltmate CM, Duska LR, Chang Y, et al.  Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol. 1999;73:407–411
  11. Onsrud M, Aalders J, Abeler V, et al.  Endometrial carcinoma with cervical involvement (stage II) (Prognostic factors and value of combined radiological-surgical treatment). Gynecol Oncol. 1982;13:76–86
  12. Wallin TE, Malkasian GD, Gaffey TA, et al.  Stage II cancer of the endometrium (A pathologic and clinical study). Gynecol Oncol. 1984;18:1–17
  13. Larson DM, Copeland LJ, Gallager HS, et al.  Prognostic factors in stage II endometrial carcinoma. Cancer. 1987;60:1358–1361
  14. Lanciano RM, Curran WJ, Greven KM, et al.  Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol. 1990;39:368–373
  15. Bush RS. Carcinoma of the ovary (Natural history). In:  Carter RL editors. Malignancies of the ovary, uterus and cervix (The management of malignant disease). London, England: Edward Arnold; 1979;p. 34; Series #2
  16. Mundt AJ, Connell PP. Do conventional pathologic features lose their prognostic significance following postoperative radiation therapy in pathologic stage I-II endometrial adenocarcinoma?. Int J Cancer. 2000;90:224–230
  17. Greven KM, Corn BW, Case D, et al.  Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?. Int J Radiat Oncol Biol Phys. 1997;39:413–418
  18. Algan O, Tabesh T, Hanlon A, et al.  Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer. Int J Radiat Oncol Biol Phys. 1996;35:925–933
  19. Kadar N, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus (Implications for therapy). Obstet Gynecol. 1992;80:655–659
  20. Greven KM, Corn B, Lanciano RM, et al.  Pathologic stage III endometrial carcinoma (Significance of extrauterine sites). Int J Cancer (Radiat Oncol Invest). 1996;4:122–128

PII: S0360-3016(02)02813-4

International Journal of Radiation Oncology * Biology * Physics
Volume 53, Issue 4 , Pages 862-867 , 15 July 2002

Article Tools

* Image Usage & Resolution